Sign up, and you'll be able to ignore users whose posts you don't want to see. Sign up
Oct 4, 2024
8:10:54am
Skeptical Optimist Intervention Needed
The FDA took Tirzepatide (generic Mounjaro) off the shortage list yesterday, meaning
it can no longer be compounded for a lower cost from a compounding pharmacy. If you have been taking compounded Tirzepatide, you will no longer be able to get it and will need to pay full price for the brand name drug (Mounjaro or Zepbound) - currently close to $2k per month. Tirzepatide had a little better weight loss response and fewer side effects than other GLP-1 Agonist drugs.

Semaglutide (Ozempic) is still on the shortage list, so you can still get it compounded for the time being. No idea when it's going to be removed, and Ozempic has had higher demand than Mounjaro, so it could be some time. But if you have been thinking of taking compounded Semaglutide for weight loss, you probably want to do it sooner than later before $1800/month is the only option rather than the $200-400/month compounded.
This message has been modified
Originally posted on Oct 4, 2024 at 8:10:54am
Message modified by Skeptical Optimist on Oct 4, 2024 at 8:12:15am
Skeptical Optimist
Previous username
workindev
Bio page
Skeptical Optimist
Joined
Aug 2, 2006
Last login
Oct 4, 2024
Total posts
83,101 (4,446 FO)